[PDF] Top 20 An Al-Jazeera Effect in the US? A Review of the Evidence
Has 10000 "An Al-Jazeera Effect in the US? A Review of the Evidence" found on our website. Below are the top 20 most common "An Al-Jazeera Effect in the US? A Review of the Evidence".
An Al-Jazeera Effect in the US? A Review of the Evidence
... of Al Jazeera Arabic's material on the five major networks (ABC, CBS, NBC, FOX and CNN) at the peak of the war in Afghanistan strongly contradicts their findings and indicates that Al Jazeera's news ... See full document
9
Dulaglutide: an evidence-based review of its potential in the treatment of type 2 diabetes
... Evidence review: Dulaglutide has been shown to have similar efficacy and safety to other newer GLP-1 RAs, and better glycemic control than ...adverse effect profile to other GLP-1 RAs in the class, ... See full document
11
An evidence-based review of the potential role of icatibant in the treatment of acute attacks in hereditary angioedema type I and II
... A search of English-language scientific literature was carried out on PubMed and ClinicalTrials.gov using the following key words: hereditary angioedema and icatibant. Searches were last updated on February 28, 2012. ... See full document
10
Ibrutinib: an evidence-based review of its potential in the treatment of advanced chronic lymphocytic leukemia
... Growing evidence has shown that signaling pathways such as the B cell receptor and NFkB are implicated in the survival and proliferation of the CLL cells which are ultimately associated with persistence of the ... See full document
9
Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
... Evidence review: Results from clinical trials of dupilumab in adults with moderate-to-severe AD have shown that weekly or biweekly dupilumab injections significantly improve clinical and ... See full document
8
Enzalutamide: an evidence-based review of its use in the treatment of prostate cancer
... Evidence review: Peer reviewed articles published and listed in Medline Search were reviewed. In addition, relevant ASCO and ESMO abstracts were searched. The activ- ity of enzalutamide is mediated by ... See full document
9
Ustekinumab: an evidence-based review of its effectiveness in the treatment of psoriasis
... Evidence review: There is clear evidence that ustekinumab is effective in the treatment of moderate to severe psoriasis. Phase III trials (PHOENIX 1 and 2) demonstrated a statistically significant ... See full document
12
An evidence-based review of the potential benefits of taliglucerase alfa in the treatment of patients with Gaucher disease
... This review considers the existing evidence for therapeutic efficacy of taliglucerase alfa in the treatment of the non-neuronopathic manifesta- tions of Gaucher ... See full document
6
Mavrilimumab: an evidence based review of its potential in the treatment of rheumatoid arthritis
... Abstract: Rheumatoid arthritis (RA) management has greatly improved with the development of biologic disease modifying antirheumatic drugs, but a proportion of patients do not improve despite the biologic drugs currently ... See full document
8
Rasburicase in the management of tumor lysis: an evidence-based review of its place in therapy
... Separate searches of the biomedical literature (Medline) were conducted using PubMed to cover the period up to and including August 2014, with the key phrases “tumor lysis syndrome” and “recombinant urate oxidase”, and ... See full document
16
<p>An Evidence-Based Review On The Use Of Perampanel For The Treatment Of Focal-Onset Seizures In Pediatric Patients</p>
... systematic review of the data on perampanel in children and adolescents with focal-onset ...le. Evidence-based data are currently available for children 12 years of age and ... See full document
10
An evidence-based review of natalizumab therapy in the management of Crohn’s disease
... this review, evidence-based data on the indications, efficacy and safety of natalizumab will be presented and its role in the management of patients with Crohn’s disease will be ... See full document
8
An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: place in therapy
... Abstract: Certolizumab pegol (CZP) is a pegylated humanized tumor necrosis factor-α inhibitor (TNFi) approved for the treatment of psoriatic arthritis (PsA) in Europe, the USA, and Latin American countries. CZP ... See full document
8
Iloperidone in the treatment of schizophrenia: an evidence-based review of its place in therapy
... Evidence review: Clinical trials, observational studies and meta-analyses reached a common consensus that iloperidone is as effective as haloperidol, risperidone and ziprasidone in reduc- ing schizophrenia ... See full document
13
Dapagliflozin: an evidence-based review of its potential in the treatment of type-2 diabetes
... Abstract: Dapagliflozin is a sodium-glucose co-transporter-2 inhibitor that lowers plasma glucose by decreasing its renal reabsorption. The resulting excretion of glucose in the urine (glucosuria) has transformed what ... See full document
8
Daptomycin: an evidence-based review of its role in the treatment of Gram-positive infections
... 74. Berti AD, Wergin JE, Girdaukas GG, Hetzel SJ, Sakoulas G, Rose WE. Altering the proclivity towards daptomycin resistance in methicillin- resistant Staphylococcus aureus using combinations with other antibiotics. ... See full document
12
An evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma
... Abstract: Proteasome inhibition represents one of the more important therapeutic targets in the treatment of multiple myeloma (MM), since by suppressing nuclear factor-κB activity, which promotes myelomagenesis, it makes ... See full document
8
Brodalumab: an evidence-based review of its potential in the treatment of moderate-to-severe psoriasis
... et al, two cases of grade 3 neutropenia were found in the 210 mg brodalumab group; the adverse events reported more frequently in the brodalumab groups were nasopharyngitis (8%), upper respiratory tract infection ... See full document
9
An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation
... by US Food and Drug Administration for stroke prevention in patients with nonvalvular atrial ...provide us with information about possible alternatives to ... See full document
11
Turoctocog alfa: an evidence-based review of its potential in the treatment of hemophilia A
... The efficacy of turoctocog alfa for PTPs is similar to that of previous FVIII products not only for prevention and treatment of bleeding episodes but also for health-related quality o[r] ... See full document
6
Related subjects